Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 2.01% is 48% below its 5-year average of 3.84%, near the low end of its 5-year range (0.88%–9.54%).
34.10% below its 12-month average of 3.05%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.44%.
RETURN ON ASSETS (ROA)
2.01%
RETURN ON ASSETS (ROA) AVG TTM
3.05%
RETURN ON ASSETS (ROA) AVG 3Y
3.16%
RETURN ON ASSETS (ROA) AVG 5Y
3.84%
RETURN ON ASSETS (ROA) AVG 10Y
8.26%
RETURN ON ASSETS (ROA) AVG 15Y
7.83%
RETURN ON ASSETS (ROA) AVG 20Y
7.83%
CURRENT VS TTM AVG
-34.10%
CURRENT VS 3Y AVG
-36.39%
CURRENT VS 5Y AVG
-47.70%
CURRENT VS 10Y AVG
-75.65%
CURRENT VS 15Y AVG
-74.32%
CURRENT VS 20Y AVG
-74.32%
SECTOR MEDIAN · HEALTHCARE
4.85%
median of 100 covered companies
CURRENT VS SECTOR MEDIAN
-58.56%
vs the sector median at left
ICON Public Limited Company
Market Cap
$12.41B
Return on Assets (ROA)
2.01%
TTM Avg
3.05%
3Y Avg
3.16%
5Y Avg
3.84%
Market Cap
$12.51B
Return on Assets (ROA)
8.13%
TTM Avg
5.32%
3Y Avg
4.08%
5Y Avg
2.47%
Market Cap
$12.14B
Return on Assets (ROA)
-5.37%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
Market Cap
$11.88B
Return on Assets (ROA)
8.33%
TTM Avg
7.48%
3Y Avg
6.38%
5Y Avg
5.99%
Market Cap
$13.43B
Return on Assets (ROA)
-10.75%
TTM Avg
-43.49%
3Y Avg
-42.71%
5Y Avg
-41.26%
Market Cap
$11.34B
Return on Assets (ROA)
7.03%
TTM Avg
4.83%
3Y Avg
6.67%
5Y Avg
7.46%
Market Cap
$11.10B
Return on Assets (ROA)
4.50%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$13.98B
Return on Assets (ROA)
-3.17%
TTM Avg
-0.94%
3Y Avg
2.58%
5Y Avg
3.75%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ICON Public Limited Company (ICLR) | $12.41B | 2.01% | 3.05% | 3.16% | 3.84% |
| Penumbra, Inc. (PEN)vs › | $12.51B | 8.13% | 5.32% | 4.08% | 2.47% |
| Baxter International Inc. (BAX)vs › | $12.14B | -5.37% | -3.64% | -1.62% | 0.47% |
| Encompass Health Corporation (EHC)vs › | $11.88B | 8.33% | 7.48% | 6.38% | 5.99% |
| DaVita Inc. (DVA)vs › | $11.47B | 4.79% | 4.84% | 4.27% | 4.56% |
| Tempus AI, Inc. (TEM)vs › | $13.43B | -10.75% | -43.49% | -42.71% | -41.26% |
| Bio-Techne Corporation (TECH)vs › | $11.34B | 7.03% | 4.83% | 6.67% | 7.46% |
| The Cooper Companies, Inc. (COO)vs › | $11.10B | 4.50% | 3.10% | 3.02% | 7.71% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.98B | -3.17% | -0.94% | 2.58% | 3.75% |
| Universal Health Services, Inc. (UHS)vs › | $10.64B | 9.58% | 8.61% | 6.84% | 6.99% |
ROA
2.0%
ROE
3.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 1.41% |
| 2024-12-31 | 4.69% |
| 2023-12-31 | 3.60% |
| 2022-12-31 | 2.94% |
| 2021-12-31 | 0.88% |
| 2020-12-31 | 9.54% |
| 2019-12-31 | 12.86% |
| 2018-12-31 | 13.71% |
| 2017-12-31 | 12.88% |
| 2016-12-31 | 14.36% |
| 2015-12-31 | 13.94% |
| 2014-12-31 | 11.29% |
| 2013-12-31 | 7.13% |
| 2012-12-31 | 4.61% |
| 2011-12-31 | 2.21% |
| 2010-12-31 | 9.17% |
| 2009-12-31 | 10.38% |
| 2008-12-31 | 9.01% |
| 2007-12-31 | 8.07% |
| 2006-12-31 | 8.04% |
| 2005-12-31 | 3.64% |
| 2005-05-31 | 4.04% |
| 2004-05-31 | 7.68% |
| 2003-05-31 | 9.78% |
| 2002-05-31 | 9.57% |
| 2001-05-31 | 9.90% |
| 2000-05-31 | 6.06% |
| 1999-05-31 | 8.59% |
| 1998-05-31 | 0.00% |
